Omeprazol Stada (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Stada, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, erosive esophagitis and is part of Helicobacter pylori eradication regimens.

GNH USA supplies Omeprazol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring consistent quality, reliable delivery, and adherence to regulatory standards across multiple markets.

Omeprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by reducing acid exposure. Peptic ulcer disease: promotes ulcer healing by suppressing gastric acid secretion. Erosive esophagitis: allows damaged esophageal tissue to recover by maintaining a higher pH. Helicobacter pylori eradication therapy: enhances antibiotic effectiveness by creating a less acidic gastric environment.

Common Side Effects: - Headache: mild to moderate pain often reported during early treatment. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: severe colitis associated with altered gut flora. - Hypomagnesemia: low magnesium levels that can cause muscle cramps or arrhythmias. - Elevated liver enzymes: indication of hepatic stress. - Interstitial nephritis: inflammation of kidney tissue. - Increased risk of bone fractures: especially with long‑term use.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in patients with severe impairment. - Monitor for drug interactions: especially with clopidogrel, warfarin, and HIV protease inhibitors. - Use the lowest effective dose: to minimize potential adverse effects. - Avoid prolonged use without supervision: prolonged therapy may increase risk of fractures and vitamin B12 deficiency. - Store at ambient temperature: keep in the original container, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines. Review the following interactions:

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atorvastatin: increased statin exposure, raising the chance of muscle toxicity. - Methotrexate: elevated plasma levels, potentially leading to toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, requiring INR monitoring. - Digoxin: increased serum concentrations, necessitating dose adjustment.